Caris Life Sciences, Inc.

By person

18 insiders · 3 transactions

27.0×

David Dean Halbert holds 27.0 times base salary in stock. $20.71M of shares against $764.92K in salary for 2025.

Salary from the company's own proxy. The shares are what David Dean Halbert last reported holding, valued at $24.76, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Spetzler David Baxley

President

—

$14.83M (3) scheduled

−$14.83M

1,182,871

0.4186%

$29.28M

+12.5%

HALBERT DAVID D

See Remarks

—

123,599,535

43.74%

$3.06B

+589.5%

J H Whitney VI L P

10% owner

—

20,256,615

7.17%

$501.46M

+161.7%

ADAPT I Ltd. entity

10% owner

—

16,943,232

6.00%

$419.43M

+26.0%

CASTLEMAN PETER M

Director

—

10,300,227

3.64%

$254.98M

+60,522%

TSSP Sub-Fund HoldCo LLC entity

Former 10% Owner

—

1,219,271

0.4315%

$30.18M

—

HALBERT JON

Director

—

836,411

0.2960%

$20.71M

—

JOHANSEN LAURA I

Director

—

343,897

0.1217%

$8.51M

+4.0%

Knowles Jonathan Kenneth Charles

Director

—

308,979

0.1093%

$7.65M

+0.5%

Brille Brian J

See Remarks

—

230,303

0.0815%

$5.70M

—

Denton John Russel

See Remarks

—

190,699

0.0675%

$4.72M

−26.7%

Power Luke Thomas

See Remarks

—

153,771

0.0544%

$3.81M

+61,408%

PHILLIPS T DANNY

Director

—

133,060

0.0471%

$3.29M

+725.0%

Vacirca Jeff L

Director

—

62,863

0.0222%

$1.56M

+289.8%

Minor Lloyd

Director

—

31,813

0.0113%

$787.54K

+97.2%

Fredrickson David Paul

Director

—

31,813

0.0113%

$787.54K

+97.2%

Gilliam Joseph E

Director

—

29,321

0.0104%

$725.85K

+81.8%

POSTE GEORGE

Director

—

17,729

0.0063%

$438.88K

−42.1%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Spetzler David Baxley

4 Sep 2026

President

Sold after exercise

119,212

$24.76

$2.95M

Spetzler David Baxley

3 Sep 2026

President

Sold after exercise

84,900

$25.32

$2.15M

Spetzler David Baxley

3 Sep 2026

President

Sold after exercise

393,100

$24.76

$9.73M

Caris Life Sciences, Inc.

By person

Individual transactions

What was left out